![]() |
||||||
|
| IDEBENONE (pronounced: eye deb' eh known) | ||||
| Order | Idebenone 45mg www.idebenone.info | 45 mg | 60 caps | 29.95 |
| Order | Idebenone 45mg 4 bottles @ $24 = $96 free shipping | 45 mg | 4 bottles @ | 24.00 |
| Order | Idebenone 45mg 12 bottles @ $20 = $240 | 45 mg | 12 bottles @ | 20.00 |
| Order | Idebenone 150mg | 150 mg | 30 caps | 39.95 |
| Order | Idebenone 150mg 4 boxes @ $34 = $136 | 150 mg | 4 boxes @ | 34.00 |
| Order | Idebenone 150mg 12 boxes @ $28 = $336 | 150 mg | 12 boxes @ | 28.00 |
|
BRAIN PRODUCTS |
|||||||||||||||||||||||||||||||
| Order | Acetyl L-Carnitine | 500 mg | 60 caps | $19.95 | |||||||||||||||||||||||||||
| Order | Aniracetam | 750 mg | 30 caps | 26.95 | |||||||||||||||||||||||||||
| Order | CDP-Choline | 200 mg | 60 caps | 19.95 | |||||||||||||||||||||||||||
| Order | Centrophenoxine | 250 mg | 60 caps | 19.95 | |||||||||||||||||||||||||||
| Order | DMAE | 125 mg | 100 caps | 5.95 | |||||||||||||||||||||||||||
| Order | Galantamine | 8 mg | 30 caps | 23.95 | |||||||||||||||||||||||||||
| Order | Huperzine A | 100 mcg | 60 caps | 9.95 | |||||||||||||||||||||||||||
| Order | Phosphatidylserine | 100 mg | 60 caps | 29.95 | |||||||||||||||||||||||||||
| Order | Picamilon | 100 mg | 60 caps | 29.95 | |||||||||||||||||||||||||||
| Order | Piracetam telephone order price is $19.95 | 800 mg | 60 caps | 16.95 | |||||||||||||||||||||||||||
| Order | Pyritinol | 200 mg | 60 caps | 18.95 | |||||||||||||||||||||||||||
| Order | Vinpocetine | 20 mg | 60 caps | 19.95 | |||||||||||||||||||||||||||
| Order | Get SmartTM | 715 mg | 60 caps | 29.95 | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
References: www.idebenone.info 1. Parnetti L, Senin U, Mecocci P, "Cognitive enhancement therapy for Alzheimer's disease. The way forward." Drugs 1997 May; 53(5):752-768. 2. Weyer G, Babeji-Dolle RM, Hadler D, Hofmann S, Herrmann WM, "A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease." Neuropsychobiology 1997; 36(2):73-82 3. Ranen NG and colleagues, "A controlled trial of idebenone in Huntington's disease" Mov Disord 1996 Sep; 11(5):549-554 4. Ikejiri Y, Mori E, Ishii K, Nishimoto K, Yasuda M, Sasaki M, "Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS" Neurology 1996; Aug 47(2); 583-585. 5. Pisano P and colleagues, "Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy." Eur J Pharmacol 1996; 51(2):167-169. 6. Gillis JC, Benefield P, McTavish D, "Idebenone, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders." Drugs Aging 1994; Aug;5(2): 133-152. 7. Bergamasco B, Scarzella L, LaCommare P, "Idebenone, a new drug in the treatment of cognitive impariment in patinets with dementia of the Alzheimer type." Funct Neurol 1994; May;9(3):161-168 8. Nitta A and colleagues "Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats." Dept of Neuropsychopharmacology, Nagoya University, Japan. 9. Nitta A, Hasegawa T, Nabeshima T, "Oral administration of idebenone, a stimulator of NGF synthesis recovers reduced NGF content in aged rat brain." Neuosci Lett 1993 Dec 12; 163(2):219-222. 10. Kakihana M, Yamazaki N, Nagaoka A, "Effects of idebenone on the levels of acetylcholine, choline, free fatty acids and energy metabolites in the brains of rats with cerebral ischaemia." Arch Gerontol Geriatr 1989 May 8(3);247-256 11. Ihara Y, Namba S, Sato T, Shiraba T, "Mitochondrial encephalomyopathy (MELAS), pathological study and successful therapy with coenzyme Q10 and idebenone." J Neurol Sci 1989 May; 90(3):263-271. 12. Suno M, Nagaoka A, "Inhibition of brain mitochondrial swelling by idebenone." Arch Gerontol Geriatr 1989 May; 8(3):299-305. 13. Ihara Y, Namba S, Shiraba T, "Mitochondrial encephalomyopathy (MELAS), pathological study and successful therapy with coenzyme Q10 and idebenone." J Neurol Sci 1989 May; 90(3):263-271. 14. Lerman-Sagie T, Rustin P, Lev D, "Dramatic improvement in mitochondrial cardiomyopathy
following treatment with idebenone." J Inherit Metab Dis 2001 Feb;24(1):28-34. 16. Yamada K, Nitta A, Hasegawa T, "Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease." Behav Brain Res 1997 Feb;83(1-2):117-22.
|